Get started
Author

Xiaowen Wu

Observed names: GONG Ziqi, WU Xiaowen, GUO Qian, GUO Jun, KONG Yan, Wu Xiaowen, Wu, Xiaowen, X W Wu, X Wu, X. Wu, Xiao-wen Wu
ORCID: 0000-0001-7207-2466
Observed ORCID: 0000-0001-7207-2466
OpenAlex ID: A5084900138
Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients
2018 · Jiayi Yu, Xiaowen Wu, et al. · Journal of Hematology & Oncology · 184
PDF
Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma
2019 · Jiayi Yu, Junya Yan, et al. · Clinical Cancer Research · 100
Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy
2017 · Yan Kong, Xinan Sheng, et al. · Clinical Cancer Research · 100
Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors
2015 · Yan Kong, Lu Si, et al. · Clinical Cancer Research · 79
MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK Pathways
2019 · Meng Ma, Jie Dai, et al. · Theranostics · 66
Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis
2022 · Siming Li, Xiaowen Wu, et al. · Journal for ImmunoTherapy of Cancer · 56
PDF
Study RC48-C014: Preliminary results of RC48-ADC combined with toripalimab in patients with locally advanced or metastatic urothelial carcinoma.
2022 · Li Zhou, Huayan Xu, et al. · Journal of Clinical Oncology · 42
Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy
2019 · Longwen Xu, Zhiyuan Cheng, et al. · Journal of Translational Medicine · 41
PDF
HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population
2023 · Li Zhou, Zhiting Shao, et al. · The Oncologist · 38
PDF
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma
2023 · Lili Mao, Bin Lian, et al. · JAMA Oncology · 36
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose Interferon
2017 · Jiayi Yu, Xiaowen Wu, et al. · Translational Oncology · 34
PDF
Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapy
2017 · Huan Yu, Meng Ma, et al. · Journal of Translational Medicine · 32
PDF
Mutations in BRAF codons 594 and 596 predict good prognosis in melanoma
2017 · Xiaowen Wu, Junya Yan, et al. · Oncology Letters · 31
PDF
High G2 and S‐phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis
2018 · Tianxiao Xu, Meng Ma, et al. · Cancer Science · 30
PDF
Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trial
2023 · Xuan Wang, Xiaowen Wu, et al. · European Journal of Cancer · 29
PDF
Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitor
2017 · Junya Yan, Xiaowen Wu, et al. · European Journal of Cancer · 27
FMRP ligand circZNF609 destabilizes RAC1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma
2022 · Qingfeng Shang, Haizhen Du, et al. · Journal of Experimental & Clinical Cancer Research · 26
PDF
PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitro
2018 · Xiaowen Wu, Jiayi Yu, et al. · Cancer Biology & Therapy · 25
PDF
Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis
2020 · Junya Yan, Xiaowen Wu, et al. · Frontiers in Oncology · 23
PDF
Efficacy and safety of DV in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: Results of a phase 2 study
2025 · Xieqiao Yan, Juan Li, et al. · Med · 19
Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell Carcinoma
2022 · Xieqiao Yan, Li Zhou, et al. · Clinical Genitourinary Cancer · 19
Clinical significance of BRAFV600E mutation in circulating tumor DNA in Chinese patients with melanoma
2017 · Huan Tang, Yan Kong, et al. · Oncology Letters · 17
PDF
Analysis of TSC1 mutation spectrum in mucosal melanoma
2017 · Meng Ma, Jie Dai, et al. · Journal of Cancer Research and Clinical Oncology · 17
Advances in HER2-Targeted Treatment for Advanced/Metastatic Urothelial Carcinoma
1970 · Mengnan Qu, Li Zhou, et al. · Bladder · 17
Potential Mutations in Uveal Melanoma Identified Using Targeted Next-Generation Sequencing
2019 · Jiayi Yu, Xiaowen Wu, et al. · Journal of Cancer · 13
PDF
Works count: 143
Citation count: 1,282
H-index: 19
I10-index: 27
Year
Topic
Type